paperKB
coga / coga-kb
Help
Sign in

Chunk #22 — Discussion — RNA-binding proteins modulate tauopathy

Source
Pathological tau drives ectopic nuclear speckle scaffold protein SRRM2 accumulation in neuron cytoplasm in Alzheimer's disease.
Embedded
yes

Text

We previously identified RNA binding proteins that reside in nuclear speckles, including sut-1, sut-2/MSUT2, and parn-2/TOE1. Examination of genes required for tau pathology-driven neurodegeneration in C. elegans uncovered suppressor of tauopathy 1 (sut-1), a nuclear speckle resident protein whose loss of function prevents tau-mediated neurodegeneration; sut-1 functions in speckles and plays a role in C. elegans trans-splicing [14]. The same genetic approach uncovered sut-2 as a genetic suppressor of tauopathy [16], and subsequent translational studies revealed that the mammalian homolog of sut-2 (MSUT2) also resides in nuclear speckles and plays a critical role in tau aggregation and neurodegeneration in mice, human cells, and AD brain tissue [19, 25]. Recent studies of other nuclear speckle resident proteins revealed that the nuclear speckle resident RNA nucleases parn-1/PARN and parn-2/TOE1 play distinct roles in tau toxicity [15]. Contemporaneous work from other laboratories has also implicated RNA-binding proteins in tauopathy, including Musashi (MSI) and T-cell intracellular antigen 1 (TIA1); while they have divergent RNA-binding functions, both TIA1 and MSI co-localize with tau-containing cytoplasmic lesions and modulate tau aggregation and concomitant tauopathy phenotypes in model systems [30–33].